Autogenous Vaccines Market
Autogenous Vaccines Market Scope: Industry Analysis, Market Size, Growth, Trends till 2030
Download Autogenous Vaccines Market Report
Autogenous Vaccine Market Size and Growth
In 2023, the global autogenous vaccines market was valued at approximately USD 150 million and is projected to grow at a compound annual growth rate (CAGR) of 7.5% from 2024 to 2030. By 2030, the market size is expected to reach around USD 270 million. The growing prevalence of bacterial and viral infections in animals, coupled with rising awareness about zoonotic diseases, has played a crucial role in this growth.
Companies Covered : (Covid-19 Impact Covered)
o Elanco Animal Health
o Boehringer Ingelheim Animal Health
o Phibro Animal Health Corporation
o Huvepharma
o Ceva Animal Health
o Cambridge Technologies
o Hygieia Biological Laboratories
These companies focuses on custom vaccines, developing autogenous vaccines to meet the specific needs of veterinary practices across the U.S. A specialized provider of autogenous vaccines, particularly for the swine and bovine sectors. These companies lead the global autogenous vaccine market with their innovative approaches and extensive product lines.
Autogenous Vaccine Market Segmentation
By Application
✓ Livestock Vaccination
✓ Companion Animal Vaccination
By Product
• Bacterial Autogenous Vaccines
• Viral Autogenous Vaccines
Autogenous Vaccine Market Growth 2024-2030
$ X Billion USD
Market Size (USD)
